← SynDRA
CIFORADENANT
SynDRA canonical compound SYN0039410 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA2A ANTAGONIST
- Adenosine A2a receptor antagonist
- adenosine receptor antagonist
Cross-references
Synonyms
- V81444
- CPI-444
- V-81444
- V 81444
- 8KFO2187CP
- ciforadenantum
- RefChem:126117
- Adenosine-A2A Receptor-Targeting Agent CPI-444
- Ciforadenant [INN]
- CPI444
- Ciforadenant [USAN]
- MFCD31540410
- Ciforadenant (USAN)
- CPI-444; Triazolo-pyramidine Derivative;
- Ciforadenant [USAN:INN]
- Ciforadenant?(CPI-444)
- UNII-8KFO2187CP
- Ciforadenant (CPI-444)?
- CIFORADENANT [WHO-DD]
- SCHEMBL536782
- orb1300002
- SCHEMBL29350253
- GTPL10190
- C20H21N7O3
- EX-A1716
- BDBM50553404
- NSC801812
- s6646
- WHO 10767
- AKOS037647889
- CS-7627
- NSC-801812
- V81444;Triazolo-pyramidine derivative
- AS-75173
- SY224461
- HY-101978
- T7183
- D11547
- F865984
Look up CIFORADENANT in the interactive SynDRA portal →